127 related articles for article (PubMed ID: 37321394)
1. The association of female sex with management and mortality in patients with Staphylococcus aureus bacteraemia.
Westgeest AC; Ruffin F; Kair JL; Park LP; Korn RE; Webster ME; Visser LG; Schippers EF; de Boer MGJ; Lambregts MMC; Fowler VG
Clin Microbiol Infect; 2023 Sep; 29(9):1182-1187. PubMed ID: 37321394
[TBL] [Abstract][Full Text] [Related]
2. Clinical predictors of methicillin-resistance and their impact on mortality associated with Staphylococcus aureus bacteraemia.
Wi YM; Rhee JY; Kang CI; Chung DR; Song JH; Peck KR
Epidemiol Infect; 2018 Jul; 146(10):1326-1336. PubMed ID: 29781425
[TBL] [Abstract][Full Text] [Related]
3. A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study.
Yaw LK; Robinson JO; Ho KM
Lancet Infect Dis; 2014 Oct; 14(10):967-75. PubMed ID: 25185461
[TBL] [Abstract][Full Text] [Related]
4. Methicillin-resistant Staphylococcus aureus (MRSA) catheter-related bacteraemia in haemodialysis patients.
Cuervo G; Camoez M; Shaw E; Dominguez MÁ; Gasch O; Padilla B; Pintado V; Almirante B; Molina J; López-Medrano F; Ruiz de Gopegui E; Martinez JA; Bereciartua E; Rodriguez-Lopez F; Fernandez-Mazarrasa C; Goenaga MÁ; Benito N; Rodriguez-Baño J; Espejo E; Pujol M;
BMC Infect Dis; 2015 Oct; 15():484. PubMed ID: 26518487
[TBL] [Abstract][Full Text] [Related]
5. Knowing prior methicillin-resistant Staphylococcus aureus (MRSA) infection or colonization status increases the empirical use of glycopeptides in MRSA bacteraemia and may decrease mortality.
Robinson JO; Phillips M; Christiansen KJ; Pearson JC; Coombs GW; Murray RJ
Clin Microbiol Infect; 2014 Jun; 20(6):530-5. PubMed ID: 24224545
[TBL] [Abstract][Full Text] [Related]
6. Predictors of clinical and microbiological treatment failure in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective cohort study in a region with low MRSA prevalence.
Forstner C; Dungl C; Tobudic S; Mitteregger D; Lagler H; Burgmann H
Clin Microbiol Infect; 2013 Jul; 19(7):E291-7. PubMed ID: 23490021
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients.
Tumbarello M; de Gaetano Donati K; Tacconelli E; Citton R; Spanu T; Leone F; Fadda G; Cauda R
J Antimicrob Chemother; 2002 Sep; 50(3):375-82. PubMed ID: 12205062
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and outcomes of methicillin-resistant Staphylococcus aureus bacteraemia in critically ill patients: a case control study.
Ho KM; Robinson JO
Anaesth Intensive Care; 2009 May; 37(3):457-63. PubMed ID: 19499868
[TBL] [Abstract][Full Text] [Related]
9. Mortality associated with in-hospital bacteraemia caused by Staphylococcus aureus: a multistate analysis with follow-up beyond hospital discharge.
Wolkewitz M; Frank U; Philips G; Schumacher M; Davey P;
J Antimicrob Chemother; 2011 Feb; 66(2):381-6. PubMed ID: 21098543
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan.
Lin SH; Liao WH; Lai CC; Liao CH; Tan CK; Wang CY; Huang YT; Hsueh PR
J Antimicrob Chemother; 2010 Aug; 65(8):1792-8. PubMed ID: 20511366
[TBL] [Abstract][Full Text] [Related]
11. High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.
Wi YM; Kim JM; Joo EJ; Ha YE; Kang CI; Ko KS; Chung DR; Song JH; Peck KR
Int J Antimicrob Agents; 2012 Aug; 40(2):108-13. PubMed ID: 22633565
[TBL] [Abstract][Full Text] [Related]
12. High vancomycin minimum inhibitory concentrations with heteroresistant vancomycin-intermediate Staphylococcus aureus in meticillin-resistant S. aureus bacteraemia patients.
Wang JL; Lai CH; Lin HH; Chen WF; Shih YC; Hung CH
Int J Antimicrob Agents; 2013 Nov; 42(5):390-4. PubMed ID: 24041465
[TBL] [Abstract][Full Text] [Related]
13. Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
Kim SH; Park WB; Lee KD; Kang CI; Bang JW; Kim HB; Kim EC; Oh MD; Choe KW
J Antimicrob Chemother; 2004 Aug; 54(2):489-97. PubMed ID: 15254028
[TBL] [Abstract][Full Text] [Related]
14. Time to blood culture positivity: An independent predictor of infective endocarditis and mortality in patients with Staphylococcus aureus bacteraemia.
Siméon S; Le Moing V; Tubiana S; Duval X; Fournier D; Lavigne JP; Erpelding ML; Gustave CA; Desage S; Chirouze C; Vandenesch F; Tattevin P;
Clin Microbiol Infect; 2019 Apr; 25(4):481-488. PubMed ID: 30036664
[TBL] [Abstract][Full Text] [Related]
15. Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study.
Kuehl R; Morata L; Boeing C; Subirana I; Seifert H; Rieg S; Kern WV; Kim HB; Kim ES; Liao CH; Tilley R; Lopez-Cortés LE; Llewelyn MJ; Fowler VG; Thwaites G; Cisneros JM; Scarborough M; Nsutebu E; Gurgui Ferrer M; Pérez JL; Barlow G; Hopkins S; Ternavasio-de la Vega HG; Török ME; Wilson P; Kaasch AJ; Soriano A;
Lancet Infect Dis; 2020 Dec; 20(12):1409-1417. PubMed ID: 32763194
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the clinical features, bacterial genotypes and outcomes of patients with bacteraemia due to heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-susceptible S. aureus.
Park KH; Kim ES; Kim HS; Park SJ; Bang KM; Park HJ; Park SY; Moon SM; Chong YP; Kim SH; Lee SO; Choi SH; Jeong JY; Kim MN; Woo JH; Kim YS
J Antimicrob Chemother; 2012 Aug; 67(8):1843-9. PubMed ID: 22535621
[TBL] [Abstract][Full Text] [Related]
17. How do the epidemiology of paediatric methicillin-resistant Staphylococcus aureus and methicillin-susceptible Staphylococcus aureus bacteraemia differ?
Abernethy J; Sharland M; Johnson AP; Hope R
J Med Microbiol; 2017 Jun; 66(6):737-743. PubMed ID: 28598316
[TBL] [Abstract][Full Text] [Related]
18. Staphylococcus aureus bacteraemia in Gauteng academic hospitals, South Africa.
Fortuin-de Smidt MC; Singh-Moodley A; Badat R; Quan V; Kularatne R; Nana T; Lekalakala R; Govender NP; Perovic O;
Int J Infect Dis; 2015 Jan; 30():41-8. PubMed ID: 25448331
[TBL] [Abstract][Full Text] [Related]
19. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2017.
Coombs GW; Daley DA; Lee YT; Pang S
Commun Dis Intell (2018); 2019 Sep; 43():. PubMed ID: 31522665
[TBL] [Abstract][Full Text] [Related]
20. Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study.
Abbas M; Rossel A; de Kraker MEA; von Dach E; Marti C; Emonet S; Harbarth S; Kaiser L; Uçkay I
Clin Microbiol Infect; 2020 May; 26(5):626-631. PubMed ID: 31357013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]